The InPen app paves the way for the launch of the company’s “Smart MDI” system combining a smart insulin pen that tracks ...

The clearance allows the system to offer personalised insights for individuals managing diabetes through MDI therapies.

Plantsulin is a recently launched glucose control supplement that arrived in the world market arena. It is developed b ...

As the Mississippi State Department of Health (MSDH) continues to recognize National Diabetes Month, health officials are ...

The global insulin pens market size was valued at USD 7.46 billion in 2024 and is projected to reach from USD 8.05 billion in ...

Department of Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, United States ...

According to the autopsy report, he initially refused an offer of 10 units of insulin because he knew the dose was too low, but then changed his mind. “[T]his was the last documentation of ...

The FDA this week revised its shortage list to note that the 0.25 mg starter dose of Novo’s semaglutide-based obesity med Wegovy is now available in the U.S. The 0.25 mg presentation of the ...

All doses of Novo Nordisk’s semaglutide—sold as Ozempic for type 2 diabetes and as Wegovy for obesity—are now available, according to a Wednesday update to the FDA’s drug shortages database. Still, ...

whose readings every minute will help the iLet calculate insulin doses. When iLet users "GO BIONIC" with their diabetes management, there is no carb counting* or calculating insulin corrections ...

The price of insulin has been a major flashpoint in the conversation around rising U.S. healthcare costs. Individual stories of patients having to ration the drug or skip doses, and in a few cases ...